Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung Cancer in Singapore

Yvonne L E Ang1, Puey Ling Chia2, Kevin L M Chua3

  • 1Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|May 26, 2021
PubMed
Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking Molecular Profiling Post First-Line Osimertinib.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Why precision oncology works: lessons from gastrointestinal stromal tumours.

Exploration of targeted anti-tumor therapy·2026
Same author

A Response to the Letter to the Editor.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib.

Thoracic cancer·2026
Same author

Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study.

Cancer treatment and research communications·2026
Same author

Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial.

Nature cancer·2026

Related Experiment Videos